{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:57:24Z","timestamp":1790456244764,"version":"4.1.0"},"reference-count":311,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10,1]]},"DOI":"10.1210\/er.2012-1003","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T18:06:38Z","timestamp":1349460398000},"page":"812-841","source":"Crossref","is-referenced-by-count":248,"title":["Cardiometabolic Aspects of the Polycystic Ovary Syndrome"],"prefix":"10.1210","volume":"33","author":[{"given":"Harpal S.","family":"Randeva","sequence":"first","affiliation":[{"name":"Division of Metabolic and Vascular Health (H.S.R., B.K.T., M.O.W., K.L., H.L.), Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom;"},{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (H.S.R., M.O.W.), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bee K.","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Metabolic and Vascular Health (H.S.R., B.K.T., M.O.W., K.L., H.L.), Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin O.","family":"Weickert","sequence":"additional","affiliation":[{"name":"Division of Metabolic and Vascular Health (H.S.R., B.K.T., M.O.W., K.L., H.L.), Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom;"},{"name":"Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (H.S.R., M.O.W.), University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Lois","sequence":"additional","affiliation":[{"name":"Division of Metabolic and Vascular Health (H.S.R., B.K.T., M.O.W., K.L., H.L.), Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom;"},{"name":"Endocrine Unit (K.L.), Second Department of Obstetrics and Gynaecology, Aretceion University Hospital, Athens Medical School, 10676 Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Nestler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (J.E.N.), Virginia Commonwealth University, Richmond, Virginia 23284;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular and Medical Sciences (N.S.), University of Glasgow, Glasgow Royal Infirmary, Glasgow G31 2, Scotland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Lehnert","sequence":"additional","affiliation":[{"name":"Division of Metabolic and Vascular Health (H.S.R., B.K.T., M.O.W., K.L., H.L.), Warwick Medical School, University of Warwick, Coventry CV4 7AL, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"key":"2019041121283902600_B1","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asunci\u00f3n","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B2","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B3","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"2019041121283902600_B4","first-page":"55","article-title":"Cardiometabolic aspects of polycystic ovarian syndrome","volume":"3","author":"Cho","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"2019041121283902600_B5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11892-007-0012-8","article-title":"Metabolic syndrome and cardiometabolic risk in PCOS","volume":"7","author":"Cussons","year":"2007","journal-title":"Curr Diab Rep"},{"key":"2019041121283902600_B6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ncpendmet0755","article-title":"Cardiometabolic features of polycystic ovary syndrome","volume":"4","author":"Hoffman","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121283902600_B7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2008.04.009","article-title":"Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights","volume":"119","author":"Westerveld","year":"2008","journal-title":"Pharmacol Ther"},{"key":"2019041121283902600_B8","first-page":"1","article-title":"Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines","volume":"56","author":"Carmina","year":"2004","journal-title":"Minerva Ginecol"},{"key":"2019041121283902600_B9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/met.2011.0019","article-title":"Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women","volume":"9","author":"Anaforoglu","year":"2011","journal-title":"Metab Syndr Relat Disord"},{"key":"2019041121283902600_B11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/humrep\/der418","article-title":"Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study","volume":"27","author":"Panidis","year":"2012","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0889-8529(05)70073-6","article-title":"Insulin action in the polycystic ovary syndrome","volume":"28","author":"Dunaif","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2019041121283902600_B14","first-page":"2854","article-title":"Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features","volume":"81","author":"Morales","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00392-006-0351-5","article-title":"Gender differences in the metabolic syndrome and their role for cardiovascular disease","volume":"95","author":"Regitz-Zagrosek","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"2019041121283902600_B16","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2014a position statement of the Androgen Excess Society","volume":"92","author":"Salley","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B17","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"2019041121283902600_B19","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"7","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121283902600_B20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc11-1971","article-title":"The risk of a persistent glucose metabolism impairment after gestational diabetes mellitus is increased in patients with polycystic ovary syndrome","volume":"35","author":"Palomba","year":"2012","journal-title":"Diabetes Care"},{"key":"2019041121283902600_B21","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B22","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2265.2000.01000.x","article-title":"Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study","volume":"52","author":"Wild","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B23","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0895-4356(98)00035-3","article-title":"Mortality of women with polycystic ovary syndrome at long-term follow-up","volume":"51","author":"Pierpoint","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2019041121283902600_B24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/09513590312331290298","article-title":"Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent","volume":"17","author":"Session","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"2019041121283902600_B25","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/oxfordjournals.humrep.a138773","article-title":"The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome","volume":"9","author":"Conway","year":"1994","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI118126","article-title":"Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome","volume":"96","author":"Dunaif","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041121283902600_B27","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041121283902600_B28","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/jc.2009-0051","article-title":"Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome","volume":"94","author":"Moro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocr Rev"},{"key":"2019041121283902600_B30","doi-asserted-by":"crossref","first-page":"E731","DOI":"10.1210\/jc.2011-2839","article-title":"Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?","volume":"97","author":"Pivovarova","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B31","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1210\/jc.2004-0918","article-title":"Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys","volume":"89","author":"Bruns","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B32","first-page":"1206","article-title":"Timing of prenatal androgen excess determines differential impairment in insulin secretion and action in adult female rhesus monkeys","volume":"85","author":"Eisner","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B33","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B34","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1210\/jc.2008-0714","article-title":"Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial","volume":"93","author":"Mai","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B35","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"2019041121283902600_B37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1172\/JCI10842","article-title":"Obesity and insulin resistance","volume":"106","author":"Kahn","year":"2000","journal-title":"J Clin Invest"},{"key":"2019041121283902600_B38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.1994.tb02577.x","article-title":"Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables","volume":"41","author":"Holte","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.56.1.295","article-title":"Insulin resistance in polycystic ovary syndrome: progress and paradoxes","volume":"56","author":"Venkatesan","year":"2001","journal-title":"Recent Prog Horm Res"},{"key":"2019041121283902600_B40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.14310\/horm.2002.1236","article-title":"In overweight\/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls","volume":"8","author":"Economou","year":"2009","journal-title":"Hormones (Athens)"},{"key":"2019041121283902600_B41","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00125-008-1116-7","article-title":"Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause","volume":"51","author":"Taylor","year":"2008","journal-title":"Diabetologia"},{"key":"2019041121283902600_B42","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.286.19.2421","article-title":"Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus","volume":"286","author":"Solomon","year":"2001","journal-title":"JAMA"},{"key":"2019041121283902600_B43","first-page":"517","article-title":"Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance","volume":"86","author":"Vgontzas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B44","first-page":"942","article-title":"\u03b2-Cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041121283902600_B46","first-page":"317","article-title":"[Obesity, arterial hypertension, metabolic disorders, and polycystic ovary syndrome]","volume":"68","author":"Qui\u00f1\u00f3nez Zarza","year":"2000","journal-title":"Ginecol Obstet Mex"},{"key":"2019041121283902600_B47","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/ajpa.10364","article-title":"Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: comparison with type 2 diabetic women","volume":"124","author":"Horejsi","year":"2004","journal-title":"Am J Phys Anthropol"},{"key":"2019041121283902600_B49","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1210\/jc.2010-0868","article-title":"Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity\u2014but not a PCOS\u2014associated phenomenon","volume":"95","author":"Ketel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B50","first-page":"2586","article-title":"Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome","volume":"80","author":"Holte","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B51","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1210\/jc.2002-021816","article-title":"Exon 6 and 2 peroxisome proliferator-activated receptor-\u03b3 polymorphisms in polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1043-2760(00)00301-5","article-title":"Adipose tissue as an endocrine organ","volume":"11","author":"Ahima","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121283902600_B53","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2337\/db08-0127","article-title":"Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance","volume":"57","author":"Tan","year":"2008","journal-title":"Diabetes"},{"key":"2019041121283902600_B54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121283902600_B55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/eje.0.1450289","article-title":"Circulating leptin concentrations and ovarian function in polycystic ovary syndrome","volume":"145","author":"Pirwany","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"2019041121283902600_B56","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0015-0282(02)02995-3","article-title":"Serum leptin levels in patients with polycystic ovary syndrome","volume":"77","author":"Telli","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B57","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/molehr\/6.10.873","article-title":"No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome","volume":"6","author":"Oksanen","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"2019041121283902600_B58","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3109\/09513590.2010.487586","article-title":"Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes","volume":"26","author":"Pusalkar","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"2019041121283902600_B59","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.fertnstert.2011.04.073","article-title":"Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome","volume":"96","author":"Yildizhan","year":"2011","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B60","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1530\/eje.1.02078","article-title":"Decreased soluble leptin receptor levels in women with polycystic ovary syndrome","volume":"154","author":"Hahn","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2019041121283902600_B61","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.metabol.2007.06.027","article-title":"Leptin secretory burst mass correlates with body mass index and insulin in normal women but not in women with polycystic ovary syndrome","volume":"56","author":"Iuorno","year":"2007","journal-title":"Metabolism"},{"key":"2019041121283902600_B62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jacc.2008.09.035","article-title":"Leptin and coronary heart disease: prospective study and systematic review","volume":"53","author":"Sattar","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2019041121283902600_B63","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.2337\/diabetes.54.9.2712","article-title":"Changes of adiponectin oligomer composition by moderate weight reduction","volume":"54","author":"Bobbert","year":"2005","journal-title":"Diabetes"},{"key":"2019041121283902600_B64","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/humrep\/deg353","article-title":"Serum adiponectin levels in women with polycystic ovary syndrome","volume":"18","author":"Panidis","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B65","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"2019041121283902600_B66","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.metabol.2010.02.019","article-title":"Total and high-molecular weight adiponectin in women with the polycystic ovary syndrome","volume":"60","author":"Wickham","year":"2011","journal-title":"Metabolism"},{"key":"2019041121283902600_B67","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.fertnstert.2010.01.057","article-title":"Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study","volume":"94","author":"Trolle","year":"2010","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B68","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db07-1045","article-title":"Serum vaspin concentrations in human obesity and type 2 diabetes","volume":"57","author":"Youn","year":"2008","journal-title":"Diabetes"},{"key":"2019041121283902600_B69","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1530\/EJE-09-0737","article-title":"Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans","volume":"162","author":"von Loeffelholz","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"2019041121283902600_B70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1507\/endocrj.K10E-330","article-title":"The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome","volume":"58","author":"Koiou","year":"2011","journal-title":"Endocr J"},{"key":"2019041121283902600_B71","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor","volume":"14","author":"Samal","year":"1994","journal-title":"Mol Cell Biol"},{"key":"2019041121283902600_B72","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"2019041121283902600_B73","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2337\/db06-0259","article-title":"Serum visfatin increases with progressive \u03b2-cell deterioration","volume":"55","author":"L\u00f3pez-Bermejo","year":"2006","journal-title":"Diabetes"},{"key":"2019041121283902600_B74","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jsgi.2006.04.007","article-title":"Decreased plasma visfatin concentrations in women with gestational diabetes mellitus","volume":"13","author":"Chan","year":"2006","journal-title":"J Soc Gynecol Investig"},{"key":"2019041121283902600_B75","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00125-007-0610-7","article-title":"Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance","volume":"50","author":"Lewandowski","year":"2007","journal-title":"Diabetologia"},{"key":"2019041121283902600_B76","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.fertnstert.2006.11.120","article-title":"Increased plasma visfatin concentrations in women with polycystic ovary syndrome","volume":"88","author":"Chan","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B77","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/09513590903015478","article-title":"Serum visfatin in Asian women with polycystic ovary syndrome","volume":"25","author":"Jongwutiwes","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"2019041121283902600_B78","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1210\/jc.2006-0936","article-title":"Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin","volume":"91","author":"Tan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B79","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.fertnstert.2008.10.058","article-title":"Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome","volume":"93","author":"Ozkaya","year":"2010","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B80","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bbrc.2007.08.104","article-title":"Chemerin\u2014a new adipokine that modulates adipogenesis via its own receptor","volume":"362","author":"Roh","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121283902600_B81","first-page":"ELT25","article-title":"Leukocytosis and hyperleptinemia in obesity: is there a link?","volume":"87","author":"Perfetto","year":"2002","journal-title":"Haematologica"},{"key":"2019041121283902600_B82","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1038\/sj.ijo.0801825","article-title":"Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals","volume":"25","author":"van Dielen","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121283902600_B83","doi-asserted-by":"crossref","first-page":"34661","DOI":"10.1074\/jbc.M504868200","article-title":"Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades","volume":"280","author":"Zabel","year":"2005","journal-title":"J Biol Chem"},{"key":"2019041121283902600_B84","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.2337\/db09-0277","article-title":"Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells","volume":"58","author":"Sell","year":"2009","journal-title":"Diabetes"},{"key":"2019041121283902600_B85","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.2337\/db08-1528","article-title":"Insulin and metformin regulate circulating and adipose tissue chemerin","volume":"58","author":"Tan","year":"2009","journal-title":"Diabetes"},{"key":"2019041121283902600_B86","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.atherosclerosis.2010.08.069","article-title":"The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: role of the newly established pro-inflammatory adipokine acute-phase serum amyloid A; evidence of an adipose tissue-monocyte axis","volume":"216","author":"Tan","year":"2011","journal-title":"Atherosclerosis"},{"key":"2019041121283902600_B87","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"key":"2019041121283902600_B88","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2265.2001.01377.x","article-title":"Resistin: a new link between obesity and insulin resistance?","volume":"55","author":"Vidal-Puig","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B89","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1210\/en.2004-1421","article-title":"Recombinant human FIZZ3\/resistin stimulates lipolysis in cultured human adipocytes, mouse adipose explants, and normal mice","volume":"146","author":"Ort","year":"2005","journal-title":"Endocrinology"},{"key":"2019041121283902600_B90","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/sj.ijo.0803242","article-title":"Increase in serum resistin during weight loss in overweight subjects is related to lipid metabolism","volume":"30","author":"Koebnick","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"2019041121283902600_B91","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humrep\/deh010","article-title":"Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance","volume":"19","author":"Seow","year":"2004","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B92","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","article-title":"Increased adipose tissue expression of tumor necrosis factor-\u03b1 in human obesity and insulin resistance","volume":"95","author":"Hotamisligil","year":"1995","journal-title":"J Clin Invest"},{"key":"2019041121283902600_B93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/sj.ijo.0802187","article-title":"Tumor necrosis factor \u03b1 and insulin resistance in obese type 2 diabetic patients","volume":"27","author":"Miyazaki","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2019041121283902600_B94","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","article-title":"Elevated serum levels of tumor necrosis factor \u03b1 in normal-weight women with polycystic ovary syndrome","volume":"48","author":"Gonzalez","year":"1999","journal-title":"Metabolism"},{"key":"2019041121283902600_B95","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1210\/jcem.87.8.8715","article-title":"Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism","volume":"87","author":"Peral","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B96","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/oby.2001.54","article-title":"Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion","volume":"9","author":"Vozarova","year":"2001","journal-title":"Obes Res"},{"key":"2019041121283902600_B97","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.2337\/dc09-0477","article-title":"Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk","volume":"32","author":"Wannamethee","year":"2009","journal-title":"Diabetes Care"},{"key":"2019041121283902600_B98","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00439-003-0912-x","article-title":"The interleukin-6 (-174) G\/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians","volume":"112","author":"Vozarova","year":"2003","journal-title":"Hum Genet"},{"key":"2019041121283902600_B99","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/oby.2003.136","article-title":"Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism","volume":"11","author":"Escobar-Morreale","year":"2003","journal-title":"Obes Res"},{"key":"2019041121283902600_B100","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"2019041121283902600_B101","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1210\/jc.2003-031365","article-title":"Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity","volume":"89","author":"Escobar-Morreale","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B102","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-Reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"2019041121283902600_B103","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1210\/jcem.87.7.8634","article-title":"A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B104","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1210\/jc.2003-031096","article-title":"Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease","volume":"89","author":"Boulman","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B105","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2265.2008.03285.x","article-title":"Metformin increases fasting plasma peptide tyrosine tyrosine (PYY) in women with polycystic ovarian syndrome (PCOS)","volume":"69","author":"Tsilchorozidou","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B106","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1096\/fj.07-094144","article-title":"AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome","volume":"22","author":"Christ-Crain","year":"2008","journal-title":"FASEB J"},{"key":"2019041121283902600_B107","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1210\/jc.2002-020776","article-title":"Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels","volume":"87","author":"Pagotto","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B108","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1210\/jc.2006-0225","article-title":"Glucagon suppression of ghrelin secretion is exerted at hypothalamus-pituitary level","volume":"91","author":"Arafat","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B109","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mob.2002.119180","article-title":"Polycystic ovary syndrome: a risk for coronary artery disease?","volume":"186","author":"Wild","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121283902600_B110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"2019041121283902600_B111","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/jama.1996.03540110029028","article-title":"Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women","volume":"276","author":"Gardner","year":"1996","journal-title":"JAMA"},{"key":"2019041121283902600_B112","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1742-1241.2008.01897.x","article-title":"Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome","volume":"63","author":"Berneis","year":"2009","journal-title":"Int J Clin Pract"},{"key":"2019041121283902600_B113","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.metabol.2009.02.005","article-title":"Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population","volume":"58","author":"Glueck","year":"2009","journal-title":"Metabolism"},{"key":"2019041121283902600_B114","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Yildirim","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B115","first-page":"707","article-title":"[Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome]","volume":"129","author":"Ben\u00edtez","year":"2001","journal-title":"Rev Med Chil"},{"key":"2019041121283902600_B116","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2265.2011.03983.x","article-title":"Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters","volume":"74","author":"Joharatnam","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF03345564","article-title":"Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome","volume":"31","author":"Essah","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"2019041121283902600_B118","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2265.2011.04210.x","article-title":"Impaired gallbladder motility in women with PCOS\u2014role of free fatty acids with circulating cholecystokinin and other possible mechanism","volume":"76","author":"Isik","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B119","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.metabol.2008.11.009","article-title":"Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin","volume":"58","author":"Svendsen","year":"2009","journal-title":"Metabolism"},{"key":"2019041121283902600_B120","first-page":"73","article-title":"Polycystic ovary syndrome in adolescents","volume":"13","author":"Kent","year":"2002","journal-title":"Adolesc Med"},{"key":"2019041121283902600_B121","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF03350781","article-title":"Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset","volume":"21","author":"Ib\u00e1\u00f1ez","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"2019041121283902600_B122","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","author":"Diamanti-Kandarakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B123","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1210\/jc.2006-0399","article-title":"Serum aldosterone concentration and cardiovascular risk in women with polycystic ovarian syndrome","volume":"91","author":"Cascella","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B124","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/humrep\/16.3.556","article-title":"Prevalence of diabetes mellitus, hypertension and cardiac complaints in a follow-up study of a Dutch PCOS population","volume":"16","author":"Elting","year":"2001","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B125","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/deg218","article-title":"Cardiovascular risk factors in young Czech females with polycystic ovary syndrome","volume":"18","author":"Vrb\u00edkov\u00e1","year":"2003","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B126","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/oxfordjournals.humrep.a019028","article-title":"Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?","volume":"11","author":"Holte","year":"1996","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B127","first-page":"21","article-title":"Role of 24-hour monitoring in assessing blood pressure changes in polycystic ovary syndrome","volume":"45","author":"Orbetzova","year":"2003","journal-title":"Folia Med (Plovdiv)"},{"key":"2019041121283902600_B128","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/humrep\/dem108","article-title":"Quality of life and psychological well being in polycystic ovary syndrome","volume":"22","author":"Barnard","year":"2007","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B129","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.fertnstert.2006.11.039","article-title":"Increased risk of depressive disorders in women with polycystic ovary syndrome","volume":"87","author":"Hollinrake","year":"2007","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B130","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.fertnstert.2008.10.073","article-title":"Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters","volume":"93","author":"Pamuk","year":"2010","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B131","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1161\/01.CIR.93.11.1951","article-title":"Predictive value of electron beam computed tomography of the coronary arteries: 19-month follow-up of 1173 asymptomatic subjects","volume":"93","author":"Arad","year":"1996","journal-title":"Circulation"},{"key":"2019041121283902600_B132","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1210\/jc.2007-1343","article-title":"Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis","volume":"92","author":"Shroff","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B133","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B134","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2265.1995.tb00534.x","article-title":"Cardiac flow velocity in women with the polycystic ovary syndrome","volume":"43","author":"Prelevic","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B135","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1210\/jc.2003-032049","article-title":"The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study","volume":"89","author":"Orio","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B136","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0015-0282(01)01937-9","article-title":"Diastolic dysfunction and increased serum homocysteine concentrations may contribute to increased cardiovascular risk in patients with polycystic ovary syndrome","volume":"76","author":"Yarali","year":"2001","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B137","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/BF03345639","article-title":"Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome","volume":"31","author":"Trakakis","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"2019041121283902600_B138","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2265.2008.03506.x","article-title":"Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?","volume":"71","author":"Soares","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B139","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/diacare.24.8.1476","article-title":"Platelet dysfunction in type 2 diabetes","volume":"24","author":"Vinik","year":"2001","journal-title":"Diabetes Care"},{"key":"2019041121283902600_B140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000058367","article-title":"The plasma homocysteine levels are increased in polycystic ovary syndrome","volume":"53","author":"Loverro","year":"2002","journal-title":"Gynecol Obstet Invest"},{"key":"2019041121283902600_B141","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","article-title":"Low grade chronic inflammation in women with polycystic ovarian syndrome","volume":"86","author":"Kelly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B142","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B143","first-page":"1851","article-title":"Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome","volume":"85","author":"Mather","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B144","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1358863x03vm474oa","article-title":"Oral L-arginine improves endothelial function in healthy individuals older than 70 years","volume":"8","author":"Bode-B\u00f6ger","year":"2003","journal-title":"Vasc Med"},{"key":"2019041121283902600_B145","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/01.ATV.0000242801.38419.48","article-title":"Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease","volume":"26","author":"Mittermayer","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121283902600_B146","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","article-title":"Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine","volume":"108","author":"St\u00fchlinger","year":"2003","journal-title":"Circulation"},{"key":"2019041121283902600_B147","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(01)07184-7","article-title":"Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine","volume":"358","author":"Valkonen","year":"2001","journal-title":"Lancet"},{"key":"2019041121283902600_B148","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1210\/jc.2007-0842","article-title":"Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment","volume":"93","author":"Heutling","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B149","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1042\/CS20080218","article-title":"A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome","volume":"116","author":"Moran","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"2019041121283902600_B150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.atherosclerosis.2008.09.010","article-title":"Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects","volume":"204","author":"Rajendran","year":"2009","journal-title":"Atherosclerosis"},{"key":"2019041121283902600_B151","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2265.2007.03004.x","article-title":"Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome","volume":"68","author":"Giallauria","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B152","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199910283411804","article-title":"Heart-rate recovery immediately after exercise as a predictor of mortality","volume":"341","author":"Cole","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041121283902600_B153","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1757-2215-2-3","article-title":"Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study","volume":"2","author":"Giallauria","year":"2009","journal-title":"J Ovarian Res"},{"key":"2019041121283902600_B154","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4158\/EP.14.2.193","article-title":"Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker","volume":"14","author":"Patel","year":"2008","journal-title":"Endocr Pract"},{"key":"2019041121283902600_B155","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/j.1572-0241.1999.01451.x","article-title":"Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients","volume":"94","author":"Daniel","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"2019041121283902600_B156","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos Nutrition and Liver Study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"2019041121283902600_B157","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"2019041121283902600_B158","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/0016-5085(88)90183-7","article-title":"Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury","volume":"95","author":"Diehl","year":"1988","journal-title":"Gastroenterology"},{"key":"2019041121283902600_B159","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/gast.2002.36572","article-title":"AGA technical review on nonalcoholic fatty liver disease","volume":"123","author":"Sanyal","year":"2002","journal-title":"Gastroenterology"},{"key":"2019041121283902600_B160","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-006-0295-3","article-title":"Signalling mechanisms linking hepatic glucose and lipid metabolism","volume":"49","author":"Weickert","year":"2006","journal-title":"Diabetologia"},{"key":"2019041121283902600_B161","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.2337\/diabetes.53.11.2855","article-title":"Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study","volume":"53","author":"Sattar","year":"2004","journal-title":"Diabetes"},{"key":"2019041121283902600_B162","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1651-2227.2007.00186.x","article-title":"MRI and ultrasound for hepatic fat quantification: relationships to clinical and metabolic characteristics of pediatric nonalcoholic fatty liver disease","volume":"96","author":"Pacifico","year":"2007","journal-title":"Acta Paediatr"},{"key":"2019041121283902600_B163","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","article-title":"Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes","volume":"48","author":"Fracanzani","year":"2008","journal-title":"Hepatology"},{"key":"2019041121283902600_B164","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0028-1091983","article-title":"Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive","volume":"28","author":"Wieckowska","year":"2008","journal-title":"Semin Liver Dis"},{"key":"2019041121283902600_B165","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","article-title":"Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease","volume":"59","author":"McPherson","year":"2010","journal-title":"Gut"},{"key":"2019041121283902600_B166","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11695-010-0204-1","article-title":"A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis","volume":"21","author":"Younossi","year":"2011","journal-title":"Obes Surg"},{"key":"2019041121283902600_B167","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1478-3231.2010.02314.x","article-title":"Diagnosis of different liver fibrosis characteristics by blood tests in non-alcoholic fatty liver disease","volume":"30","author":"Cal\u00e8s","year":"2010","journal-title":"Liver Int"},{"key":"2019041121283902600_B168","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"2019041121283902600_B169","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1210\/jc.2010-1608","article-title":"Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome","volume":"96","author":"Ma","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B170","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"2019041121283902600_B171","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/9781444347319.ch16","article-title":"Polycystic ovary syndrome","volume-title":"The metabolic syndrome","author":"Sattar","year":"2011","edition":"2nd 3d"},{"key":"2019041121283902600_B172","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"2019041121283902600_B173","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1053\/j.gastro.2006.11.048","article-title":"Insulin resistance: cause or consequence of nonalcoholic steatohepatitis?","volume":"132","author":"Ahima","year":"2007","journal-title":"Gastroenterology"},{"key":"2019041121283902600_B174","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2007.04.012","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"47","author":"Cerda","year":"2007","journal-title":"J Hepatol"},{"key":"2019041121283902600_B175","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.cgh.2006.10.010","article-title":"Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"5","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2019041121283902600_B176","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.fertnstert.2004.08.020","article-title":"Abnormal aminotransferase activity in women with polycystic ovary syndrome","volume":"83","author":"Schwimmer","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B177","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/jc.2009-1834","article-title":"Apoptotic markers indicate nonalcoholic steatohepatitis in polycystic ovary syndrome","volume":"95","author":"Tan","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B178","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF03345743","article-title":"Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome","volume":"32","author":"Targher","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"2019041121283902600_B179","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","article-title":"Prevalence of non alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens","volume":"9","author":"Gutierrez-Grobe","year":"2010","journal-title":"Ann Hepatol"},{"key":"2019041121283902600_B180","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0002-9343(00)00602-1","article-title":"Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes","volume":"109","author":"Erbey","year":"2000","journal-title":"Am J Med"},{"key":"2019041121283902600_B181","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.2008.05740.x","article-title":"An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome","volume":"24","author":"Brzozowska","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"2019041121283902600_B182","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2009-2698","article-title":"Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome","volume":"95","author":"Chen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B183","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1478-3231.2007.01483.x","article-title":"Current concepts in the pathogenesis of nonalcoholic fatty liver disease","volume":"27","author":"M\u00e9ndez-S\u00e1nchez","year":"2007","journal-title":"Liver Int"},{"key":"2019041121283902600_B184","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B185","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1210\/jc.2005-2774","article-title":"Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome","volume":"91","author":"Setji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B186","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jpag.2009.03.003","article-title":"The prevalence of abnormal liver enzymes and metabolic syndrome in obese adolescent females with polycystic ovary syndrome","volume":"22","author":"Barfield","year":"2009","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2019041121283902600_B187","first-page":"77","article-title":"La sindrome del fegato iperecogeno","volume":"10","author":"Lonardo","year":"1997","journal-title":"Argomenti Gastroenterol Clin"},{"key":"2019041121283902600_B188","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Non-alcoholic fatty liver disease and increased risk of cardiovascular disease","volume":"191","author":"Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"2019041121283902600_B189","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.22009","article-title":"Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach","volume":"47","author":"Bellentani","year":"2008","journal-title":"Hepatology"},{"key":"2019041121283902600_B190","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cld.2009.07.006","article-title":"Lifestyle modification as the primary treatment of NASH","volume":"13","author":"Neuschwander-Tetri","year":"2009","journal-title":"Clin Liver Dis"},{"key":"2019041121283902600_B191","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jhep.2005.06.008","article-title":"Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease","volume":"43","author":"Suzuki","year":"2005","journal-title":"J Hepatol"},{"key":"2019041121283902600_B192","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: a randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"2019041121283902600_B193","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MOL.0b013e328317cc42","article-title":"The trials and tribulations of the treatment of nonalcoholic fatty-liver disease","volume":"19","author":"Gan","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"2019041121283902600_B194","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4158\/EP.11.5.319","article-title":"Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings","volume":"11","author":"Brown","year":"2005","journal-title":"Endocr Pract"},{"key":"2019041121283902600_B195","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000282102","article-title":"Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease","volume":"28","author":"Weiner","year":"2010","journal-title":"Dig Dis"},{"key":"2019041121283902600_B196","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1742-1241.2008.01825.x","article-title":"The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome","volume":"62","author":"Preiss","year":"2008","journal-title":"Int J Clin Pract"},{"key":"2019041121283902600_B197","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/jc.2009-0870","article-title":"Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy","volume":"94","author":"Cussons","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B198","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"2019041121283902600_B199","first-page":"231","article-title":"Sleep breathing disorders","volume-title":"Principles and practice of sleep medicine","author":"Sanders","year":"2005"},{"key":"2019041121283902600_B200","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/dc08-1776","article-title":"Obstructive sleep apnea among obese patients with type 2 diabetes","volume":"32","author":"Foster","year":"2009","journal-title":"Diabetes Care"},{"key":"2019041121283902600_B201","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1378\/chest.07-0828","article-title":"Obstructive sleep apnea and type 2 diabetes: interacting epidemics","volume":"133","author":"Tasali","year":"2008","journal-title":"Chest"},{"key":"2019041121283902600_B202","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/sleep\/31.6.795","article-title":"Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study","volume":"31","author":"Hla","year":"2008","journal-title":"Sleep"},{"key":"2019041121283902600_B203","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jacc.2008.05.002","article-title":"Sleep apnea and cardiovascular disease: an American Heart Association\/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing","volume":"52","author":"Somers","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2019041121283902600_B204","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1378\/chest.07-0800","article-title":"Obstructive sleep apnea: implications for cardiac and vascular disease","volume":"133","author":"Lopez-Jimenez","year":"2008","journal-title":"Chest"},{"key":"2019041121283902600_B205","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/ajrccm.165.5.2103001","article-title":"Obstructive sleep apnea is independently associated with insulin resistance","volume":"165","author":"Ip","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2019041121283902600_B206","doi-asserted-by":"crossref","first-page":"846","DOI":"10.7326\/0003-4819-141-11-200412070-00008","article-title":"Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite","volume":"141","author":"Spiegel","year":"2004","journal-title":"Ann Intern Med"},{"key":"2019041121283902600_B207","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2337\/dc11-zb01","article-title":"Diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea. The American Diabetes Association's 57th Annual Advanced Postgraduate Course","volume":"34","author":"Bloomgarden","year":"2011","journal-title":"Diabetes Care"},{"key":"2019041121283902600_B208","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ndt\/gfi290","article-title":"Obesity and hypertension\u2014the issue is more complex than we thought","volume":"21","author":"Narkiewicz","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2019041121283902600_B209","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J Clin Invest"},{"key":"2019041121283902600_B210","first-page":"CR117","article-title":"Long-term improvement of insulin sensitivity during CPAP therapy in the obstructive sleep apnoea syndrome","volume":"14","author":"Schahin","year":"2008","journal-title":"Med Sci Monit"},{"key":"2019041121283902600_B211","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jsmc.2007.03.008","article-title":"Sleep apnea and neuroendocrine function","volume":"2","author":"Liu","year":"2007","journal-title":"Sleep Med Clin"},{"key":"2019041121283902600_B212","first-page":"1175","article-title":"Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome","volume":"86","author":"Fogel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B213","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/jc.2005-1084","article-title":"Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome","volume":"91","author":"Tasali","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B214","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/sleep\/28.4.449","article-title":"The influence of the menstrual cycle on upper airway resistance and breathing during sleep","volume":"28","author":"Driver","year":"2005","journal-title":"Sleep"},{"key":"2019041121283902600_B215","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1378\/chest.120.5.1448","article-title":"Sleep-related disordered breathing during pregnancy in obese women","volume":"120","author":"Maasilta","year":"2001","journal-title":"Chest"},{"key":"2019041121283902600_B216","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/sleep\/27.7.1405","article-title":"Sleep disorders during pregnancy","volume":"27","author":"Pien","year":"2004","journal-title":"Sleep"},{"key":"2019041121283902600_B217","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1152\/jappl.1998.84.3.1055","article-title":"Upper airway muscle activity in normal women: influence of hormonal status","volume":"84","author":"Popovic","year":"1998","journal-title":"J Appl Physiol"},{"key":"2019041121283902600_B218","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/jc.2010-1187","article-title":"Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome","volume":"96","author":"Tasali","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B219","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Camb)"},{"key":"2019041121283902600_B220","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","author":"Solomon","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B221","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2007-0425","article-title":"Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health\u2013National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation","volume":"93","author":"Shaw","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B222","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B223","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.4158\/EP.14.9.1084","article-title":"Risk of cardiovascular events in mothers of women with polycystic ovary syndrome","volume":"14","author":"Cheang","year":"2008","journal-title":"Endocr Pract"},{"key":"2019041121283902600_B224","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0889-8545(05)70191-1","article-title":"Insulin-lowering drugs in polycystic ovary syndrome","volume":"28","author":"Iuorno","year":"2001","journal-title":"Obstet Gynecol Clin North Am"},{"key":"2019041121283902600_B226","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041121283902600_B227","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"2019041121283902600_B228","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"key":"2019041121283902600_B229","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0002-8223(00)00275-3","article-title":"Case problem: dietary recommendations to combat obesity, insulin resistance, and other concerns related to polycystic ovary syndrome","volume":"100","year":"2000","journal-title":"J Am Diet Assoc"},{"key":"2019041121283902600_B230","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/ajcn\/72.5.1135","article-title":"Effect of fat-reduced diets on 24-h energy expenditure: comparisons between animal protein, vegetable protein, and carbohydrate","volume":"72","author":"Mikkelsen","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"2019041121283902600_B231","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/humrep\/deq254","article-title":"Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial","volume":"25","author":"Palomba","year":"2010","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B232","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1210\/jc.2006-0216","article-title":"Cardiopulmonary impairment in young women with polycystic ovary syndrome","volume":"91","author":"Orio","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B233","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1210\/jc.2006-2794","article-title":"Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome","volume":"92","author":"Vigorito","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B234","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1479-828X.2001.tb01296.x","article-title":"The current status of polycystic ovary syndrome","volume":"41","author":"Kovacs","year":"2001","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2019041121283902600_B235","first-page":"1470","article-title":"Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone","volume":"84","author":"Huber-Buchholz","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B236","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1249\/MSS.0b013e31818c6c0c","article-title":"Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome","volume":"41","author":"Brown","year":"2009","journal-title":"Med Sci Sports Exerc"},{"key":"2019041121283902600_B237","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/humrep\/dem391","article-title":"Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study","volume":"23","author":"Palomba","year":"2008","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B238","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"key":"2019041121283902600_B239","first-page":"CD006133","article-title":"Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus","volume":"4","author":"Lopez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121283902600_B240","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/humrep\/deq301","article-title":"The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies","volume":"26","author":"Halperin","year":"2011","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B241","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0015-0282(16)58321-6","article-title":"Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis","volume":"65","author":"Lobo","year":"1996","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B242","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinyl estradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Ib\u00e1\u00f1ez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B243","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.896","article-title":"Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database","volume":"13","author":"Seaman","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2019041121283902600_B244","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2019041121283902600_B245","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B246","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.327.7421.951","article-title":"Metformin in polycystic ovary syndrome: systematic review and meta-analysis","volume":"327","author":"Lord","year":"2003","journal-title":"BMJ"},{"key":"2019041121283902600_B247","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(03)13493-9","article-title":"Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome","volume":"361","author":"Harborne","year":"2003","journal-title":"Lancet"},{"key":"2019041121283902600_B248","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.fertnstert.2004.02.104","article-title":"A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and\/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study","volume":"82","author":"Hoeger","year":"2004","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B249","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1210\/jcem.85.8.6738","article-title":"Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome","volume":"85","author":"Pasquali","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B250","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/humrep\/dei311","article-title":"Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study","volume":"21","author":"Tang","year":"2006","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B251","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1210\/jc.2004-2283","article-title":"Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses","volume":"90","author":"Harborne","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B252","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B253","first-page":"25","article-title":"Neuroendocrine and endocrine dysfunction in the hyperinsulinemic PCOS patient: the role of metformin","volume":"37","author":"Weickert","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"2019041121283902600_B254","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejogrb.2010.12.041","article-title":"Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome","volume":"156","author":"Yasmin","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121283902600_B255","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ncpendmet0511","article-title":"Is metformin the treatment of choice for anovulation in polycystic ovary syndrome?","volume":"3","author":"Balen","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"2019041121283902600_B256","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome","volume":"3","author":"Lord","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121283902600_B257","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.fertnstert.2008.04.073","article-title":"Metformin in the treatment of infertility in polycystic ovarian syndrome: an alternative perspective","volume":"90","author":"Nestler","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B258","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"2019041121283902600_B259","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/humrep\/deq100","article-title":"PCOSMIC: a multi-centre randomized trial in women with polycystic ovary syndrome evaluating metformin for infertility with clomiphene","volume":"25","author":"Johnson","year":"2010","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejogrb.2011.03.024","article-title":"The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications","volume":"157","author":"De Leo","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2019041121283902600_B261","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B262","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","volume":"1","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121283902600_B263","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4158\/EP.13.4.373","article-title":"Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis","volume":"13","author":"Sharma","year":"2007","journal-title":"Endocr Pract"},{"key":"2019041121283902600_B264","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjmed.2007.09.016","article-title":"Meta-analysis: metformin treatment in persons at risk for diabetes mellitus","volume":"121","author":"Salpeter","year":"2008","journal-title":"Am J Med"},{"key":"2019041121283902600_B265","doi-asserted-by":"crossref","first-page":"E1262","DOI":"10.1210\/jc.2011-0555","article-title":"Early metformin therapy (age 8\u201312 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence","volume":"96","author":"Ib\u00e1\u00f1ez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B266","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B267","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 \u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"2019041121283902600_B268","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.fertnstert.2008.03.082","article-title":"Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome","volume":"91","author":"Luque-Ram\u00edrez","year":"2009","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B269","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2265.2006.02551.x","article-title":"Metformin therapy improves coronary microvascular function in patients with polycystic ovary syndrome and insulin resistance","volume":"65","author":"Topcu","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B270","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1038\/sj.onc.1211024","article-title":"The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level","volume":"27","author":"Ben Sahra","year":"2008","journal-title":"Oncogene"},{"key":"2019041121283902600_B271","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1210\/jc.2007-0441","article-title":"Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome","volume":"92","author":"Palomba","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B272","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2004-0176","article-title":"Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome","volume":"90","author":"Jayagopal","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B273","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2265.2006.02693.x","article-title":"Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome","volume":"66","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B274","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/humrep\/den454","article-title":"An RCT of metformin versus orlistat for the management of obese anovulatory women","volume":"24","author":"Metwally","year":"2009","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B275","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0015-0282(03)02162-9","article-title":"Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome","volume":"80","author":"Sabuncu","year":"2003","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B276","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.fertnstert.2007.05.002","article-title":"Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial","volume":"89","author":"Lindholm","year":"2008","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B277","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803777","article-title":"Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study","volume":"32","author":"Florakis","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"2019041121283902600_B278","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"2019041121283902600_B279","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B280","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.soard.2005.02.008","article-title":"Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass","volume":"1","author":"Eid","year":"2005","journal-title":"Surg Obes Relat Dis"},{"key":"2019041121283902600_B281","doi-asserted-by":"crossref","first-page":"615S","DOI":"10.1093\/ajcn\/55.2.615s","article-title":"Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement","volume":"55","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"2019041121283902600_B282","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B283","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2265.2001.01245.x","article-title":"Smaller LDL particle size in women with polycystic ovary syndrome compared to controls","volume":"54","author":"Dejager","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B284","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0015-0282(99)00401-X","article-title":"Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors","volume":"72","author":"Legro","year":"1999","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B285","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0015-0282(02)03111-4","article-title":"Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus","volume":"77","author":"Ovalle","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B286","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2265.1996.674495.x","article-title":"Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries","volume":"44","author":"Robinson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B287","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0002-9378(88)80099-1","article-title":"The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome","volume":"159","author":"Wild","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121283902600_B288","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B289","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/jcem-57-2-356","article-title":"Insulin resistance in nonobese patients with polycystic ovarian disease","volume":"57","author":"Chang","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B290","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diab.38.9.1165","article-title":"Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome","volume":"38","author":"Dunaif","year":"1989","journal-title":"Diabetes"},{"key":"2019041121283902600_B291","first-page":"1134","article-title":"The -597 G\u2192A and -174 G\u2192C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism","volume":"87","author":"Villuendas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B292","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s001250051598","article-title":"Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro","volume":"44","author":"Assert","year":"2001","journal-title":"Diabetologia"},{"key":"2019041121283902600_B293","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2337\/diab.44.8.924","article-title":"Hyperglycemia-induced thrombin formation in diabetes. The possible role of oxidative stress","volume":"44","author":"Ceriello","year":"1995","journal-title":"Diabetes"},{"key":"2019041121283902600_B294","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF00404044","article-title":"Evidence for a hyperglycaemia-dependent decrease of antithrombin III-thrombin complex formation in humans","volume":"33","author":"Ceriello","year":"1990","journal-title":"Diabetologia"},{"key":"2019041121283902600_B295","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/S0002-9378(96)70665-8","article-title":"Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study","volume":"174","author":"Guzick","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"2019041121283902600_B296","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.ATV.15.8.1114","article-title":"Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria","volume":"15","author":"Kario","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121283902600_B297","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B298","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1210\/jcem.87.5.8513","article-title":"Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity","volume":"87","author":"Legro","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B299","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0015-0282(02)03153-9","article-title":"Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated","volume":"78","author":"Legro","year":"2002","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B300","doi-asserted-by":"crossref","first-page":"H1480","DOI":"10.1152\/ajpheart.2001.280.4.H1480","article-title":"Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus","volume":"280","author":"Li","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2019041121283902600_B301","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1161\/hq0801.093667","article-title":"Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects","volume":"21","author":"Pandolfi","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121283902600_B302","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0015-0282(97)00486-X","article-title":"The plasminogen activator system in women with polycystic ovary syndrome","volume":"69","author":"Atiomo","year":"1998","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B303","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.fertnstert.2005.04.021","article-title":"Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome","volume":"84","author":"Palomba","year":"2005","journal-title":"Fertil Steril"},{"key":"2019041121283902600_B304","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2265.1996.00863.x","article-title":"Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome","volume":"45","author":"Sampson","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121283902600_B305","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/humrep\/13.3.651","article-title":"Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries","volume":"13","author":"Agrawal","year":"1998","journal-title":"Hum Reprod"},{"key":"2019041121283902600_B306","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004872-200202000-00001","article-title":"Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk","volume":"20","author":"Simon","year":"2002","journal-title":"J Hypertens"},{"key":"2019041121283902600_B307","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","author":"Talbott","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2019041121283902600_B308","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B309","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"5","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2019041121283902600_B310","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.1210\/jc.2005-0965","article-title":"Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study","volume":"90","author":"Orio","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121283902600_B311","doi-asserted-by":"crossref","first-page":"402.e1","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","volume":"196","author":"Legro","year":"2007","journal-title":"Am J Obstet Gynecol"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/33\/5\/812\/8859941\/edrv0812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T01:47:01Z","timestamp":1714441621000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/33\/5\/812\/2354900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,24]]},"references-count":311,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,7,24]]},"published-print":{"date-parts":[[2012,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2012-1003","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,24]]}}}